Introduction
Cryptococcus neoformans is an invasive fungus in organ transplant recipients, with reported incidence of cryptococcosis being 3-4% 1 in renal transplant recipients. It is the pathogen most frequently implicated in infections of the central nervous system (CNS) during the late posttransplantation period, and often the cause of subacute meningitis-encephalitis. Mortality rate is around 50% despite antifungal treatment. 1 We report a patient who presented with the full spectrum of disseminated cryptococcal disease involving the CNS, lung, and skin, four years after successful kidney transplant. We were able to identify the pathogen from all three sites of involvement.
The main purpose of this case report is to highlight cortical laminar necrosis (CLN) as a rare neurologic complication i n d i a n j o u r n a l o f t r a n s p l a n t a t i o n 9 ( 2 0 1 5 ) 1 0 5 -1 0 8 a r t i c l e i n f o secondary to refractory status epilepticus (RSE) in a case of cryptococcal meningitis (CM). We could find only 2 reported cases of CLN related to prolonged status epilepticus in the literature, and to our knowledge this is the first case in a renal transplant patient.
Case history
A 56-year-old male was brought to the hospital with complaints of vomiting and altered sensorium.
He was a known case of diabetes mellitus, hypertension, peripheral vascular disease, and ischemic heart disease for which he underwent CABG. In 2010, he developed ESRD for which he underwent living unrelated donor renal transplantation at another center. He was on triple immunosuppression with tacrolimus, mycophenolate mofetil, and prednisolone. Allograft function was stable.
On admission, he was conscious but drowsy. He was afebrile and hemodynamically stable. His skin showed multiple umbilicated papules on the nose, cheek, and dorsum of fingers ( Fig. 1 ). Neurologically, there was no focal neurologic deficit with a Glasgow coma scale of 13/15. Laboratory values on admission showed 1 + protein, 5-6 RBC/hpf, and 4-5 WBC/hpf on routine urinalysis. Hemoglobin was 15.1 g/dl, WBC 13,900 per cubic mm with 90% neutrophils and platelets 238,000 per cubic mm. His serum creatinine was 1.49 mg/dl while the rest of his renal and liver parameters were normal.
A CT Brain showed an old infarct in the right basal ganglia and no other significant abnormality. A CSF examination revealed 80 WBCs per cubic mm with 15% neutrophils and 85% lymphocytes; protein 104.2 mg/dl, and glucose of 5 mg/dl (parallel blood glucose of 100 mg%). The India ink preparation showed capsulated budding yeast suggestive of cryptococcal species (Fig. 1) . A diagnosis of CM was made and he was commenced on liposomal amphotericin B (5 mg/kg/day) and flucytosine. Tacrolimus and MMF were discontinued.
An MRI Brain with gadolinium showed abnormal diffuse pachymeningeal thickening and intense enhancement along bilateral cerebral convexities, interhemispheric fissure, tentorium, and cerebellar folia suggestive of meningitis. There was no focal enhancing lesion or hydrocephalus.
After an initial improvement in sensorium, 2 days later he became excessively drowsy and dyspneic. An HRCT chest showed features suggestive of infective bronchiolitis. Bronchoalveolar lavage showed few pus cells, moderate number of RBCs and India ink staining confirmed capsulated budding yeast suggestive of Cryptococcus species.
A scraping from the right nasal skin lesion was positive for India ink staining, showing multiple capsulated budding yeast.
After another 12 h, he had generalized tonic clonic convulsions which were treated with midazolam and levetiracetam. He was intubated for airway protection. A CT Brain i n d i a n j o u r n a l o f t r a n s p l a n t a t i o n 9 ( 2 0 1 5 ) 1 0 5 -1 0 8 showed enlarged subarachnoid spaces surrounding both the cerebral hemispheres and no evidence of venous sinus thrombosis or intracranial bleed. Over the next several hours, he continued to have both clinical focal seizures as well as electrographic epileptiform activity on EEG for which phenytoin, sodium valproate, and topiramate were sequentially added. Despite this, there was persistent epileptiform activity on EEG and propofol infusion was commenced. However, seizures continued despite 12 h of propofol. In view of super-RSE, he was started on thiopentone infusion.
He remained clinically unresponsive (on thiopentone). A repeat CSF study done after 2 days showed 5 WBC per cubic mm, protein 161 mg/dl, and glucose of 5 mg/dl. The cryptococcal antigen was still positive in CSF, titer 1:1000.
After another 2 days, thiopentone was tapered and stopped. A third CSF study showed improvement: 8 WBC, protein 154.2 mg/dl, and glucose of 40 mg/dl. However, despite withdrawal of thiopentone for over 48 h, he continued to remain comatose with poorly reactive pupils and absent oculocephalic reflexes, at 2 weeks after admission. Clinical seizures had stopped, and there was marked reduction of EEG abnormalities.
At 2½ weeks after admission, a second MRI Brain revealed that both cerebral hemispheres had a new and extensive cortical T2 hyperintensity with restriction on diffusion and post-contrast enhancement suggestive of CLN. Extensive pachymeningeal enhancement and ring-enhancing T2 hyperintense lesions in bilateral gangliocapsular regions were now also seen, suggestive of cryptococcomas, that were absent on the first MRI scan (Fig. 2) . At 3 weeks, there were signs of clinical improvementsome spontaneous eye opening, return of sluggish pupillary reactivity and better dolls eye reflexes, and weak flexion of left extremities to pain. He came off the ventilator. However, despite being 'awake', he did not regain consciousness and had no meaningful awareness of the external environment. He remained in this persistent vegetative state at 4 weeks and succumbed to septic shock after 1 week.
Discussion
CLN is usually an irreversible brain injury with most patients either progressing to brain death or remaining in a persistent vegetative state. It is a specific type of cortical infarction, usually seen in the setting of anoxic encephalopathy as a laminar high signal lesion on precontrast T1-weighted images and was first described by Sawada et al. 5 Other etiologies like i n d i a n j o u r n a l o f t r a n s p l a n t a t i o n 9 ( 2 0 1 5 ) 1 0 5 -1 0 8 hypoglycaemia, status epilepticus, neuro-lupus, ischemic stroke, CNS vasculitis, immunosuppressive chemotherapy, and infections have been implicated. 2, [4] [5] [6] In RSE, the mechanism of hypoxic ischemic injury leading to CLN is an increase in cerebral metabolic demand for glucose and oxygen during seizures. 6 If compensatory increase in cerebral blood flow is insufficient to meet increased metabolic demand, adenosine triphosphate depletion and lactate accumulation occur, leading to a 'hypermetabolic' necrosis of cerebral cortical neuron. 3 Excitotoxic mechanisms mediated by NMDA and non-NMDA receptors resulting in Ca 2+ entry and release of Ca 2+ from intracellular stores also play a role in neuronal injury in RSE. 4 Our patient had a severe CM, which did not respond to early and adequate therapy with 2 antifungal drugs in full doses, for more than the recommended duration of 2 weeks. He developed RSE before being controlled by barbiturate anesthesia. While the mortality of CM is known, we could not find published reports of CM patients who did not respond to complete and appropriately dosed therapy with 2 antifungal agents, which were initiated in an early stage of clinical presentation.
This case demonstrates that CM in the post-transplant setting can be very aggressive and may not respond to induction treatment. Possible reasons for this include a primary resistance to amphotericin B and flucytosine, and an overwhelming burden of fungal infection. While seizures are known to occur in CM, we could not find reports of status epilepticus, that too of a refractory nature. It is conceivable that poor drug response, as evidenced by a lack of significant improvement in the temporal profile of CSF parameters despite treatment, contributed to meningeal and cerebral inflammation and infection, causing ongoing and persistent seizure activity. Further, CLN is an even rarer neurologic complication of RSE, more so in post-transplant CM.
